70639-78-0 Usage
General Description
2-(1H)-quinolinene-6-carboxylic acid, also known as quinaldic acid, is a chemical compound with the molecular formula C10H7NO2. It is a derivative of quinoline and is commonly used as a building block in the synthesis of pharmaceuticals and agrochemicals. Quinaldic acid has been studied for its potential biological activities, including anti-inflammatory, antioxidant, and antimicrobial properties. It is also used as a ligand in coordination chemistry and as a precursor for the synthesis of various heterocyclic compounds. Quinaldic acid has a role in the development of new drugs and materials due to its versatile reactivity and potential biological activities.
Check Digit Verification of cas no
The CAS Registry Mumber 70639-78-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,0,6,3 and 9 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 70639-78:
(7*7)+(6*0)+(5*6)+(4*3)+(3*9)+(2*7)+(1*8)=140
140 % 10 = 0
So 70639-78-0 is a valid CAS Registry Number.
InChI:InChI=1/C10H7NO3/c12-9-4-2-6-5-7(10(13)14)1-3-8(6)11-9/h1-5H,(H,11,12)(H,13,14)
70639-78-0Relevant articles and documents
INHIBITORS OF ENL/AF9 YEATS
-
, (2021/06/26)
Methods and compositions for treating leukemia are disclosed. Acylated 6-aminoindoles, acylated 6-aminopyrrolopyridines and acylated 3-aminopyrrolo[3,2-c]pyridazines of the following formula inhibit ENL/AF9 YEATS and are therefore useful for treating leukemia.
Carbostyril derivatives
-
, (2008/06/13)
Disclosed are carbostyril derivatives and their salts of the formulas STR1 The compounds have anti-peptic ulcer effects, and are useful as a treating agent for curing peptic ulcers in the digestive system, such as ulcers in the stomach and in the duodenum. The compounds particularly have prophylaxis and curing effects for treating chronic ulcers, for example experimental acetic acid-induced ulcers and cautery ulcers, with both low toxicity and few side-effects. Also disclosed are processes for preparing the compounds and for preparing pharmaceutical compositions containing them.